A 54-year-old with type 2 diabetes, uACR 150 mg/g, eGFR 65, is on ACE inhibitor and SGLT2 inhibitor. Which additional agent reduces CKD progression an...

Question

A 54-year-old with type 2 diabetes, uACR 150 mg/g, eGFR 65, is on ACE inhibitor and SGLT2 inhibitor. Which additional agent reduces CKD progression and CV events with persistent albuminuria?

Accepted Answer

Add finerenone

Answer

Add hydrochlorothiazide

Answer

Add alpha-blocker

Answer

No further therapy helps

Answer

Add high-dose vitamin E

us-abfm MCQ (SBA): Diabetic Kidney Disease

A 54-year-old with type 2 diabetes, uACR 150 mg/g, eGFR 65, is on ACE inhibitor and SGLT2 inhibitor. Which additional agent reduces CKD progression and CV events with persistent albuminuria?